共 50 条
- [41] Encorafenib (enco) plus binimetinib (bini) plus pembrolizumab (pembro) for unresectable locally advanced or metastatic BRAF V600-mutant melanoma: Results from STARBOARD safety lead-in (SLI).JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Schadendorf, Dirk论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyDummer, Reinhard论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyRobert, Caroline论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyRibas, Antoni论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanySullivan, Ryan J.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyPanella, Timothy J.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyMcKean, Meredith论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanySantos, Edgardo S.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyClancy, Jill S.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyThakur, Mahgull Nazar论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyPolli, Anna论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyDi Pietro, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, GermanyAscierto, Paolo Antonio论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, Germany
- [42] A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain MetastasesONCOLOGIST, 2015, 20 (07): : 789 - 797Harding, James J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Weill Cornell Med Coll, Dept Med, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USACatalanotti, Federica论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp Res Labs, Human Oncol & Pathogenesis Program, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USAMunhoz, Rodrigo R.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USACheng, Donavan T.论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp Res Labs, Human Oncol & Pathogenesis Program, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USAYaqubie, Amin论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USAKelly, Nicole论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USAMcdermott, Gregory C.论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Coll, Dept Med, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USAKersellius, Romona论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Coll, Dept Med, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USAMerghoub, Taha论文数: 0 引用数: 0 h-index: 0机构: Sloan Kettering Inst, Dept Immunol, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USALacouture, Mario E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USACarvajal, Richard D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USAPanageas, Katherine S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USABerger, Michael F.论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp Res Labs, Human Oncol & Pathogenesis Program, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USARosen, Neal论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Weill Cornell Med Coll, Dept Med, New York, NY USA Sloan Kettering Inst, Dept Mol & Pharmacol, New York, NY USA Sloan Kettering Inst, Chem Programs, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USASolit, David B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Weill Cornell Med Coll, Dept Med, New York, NY USA Mem Hosp Res Labs, Human Oncol & Pathogenesis Program, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USAChapman, Paul B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Weill Cornell Med Coll, Dept Med, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
- [43] Updated efficacy and safety from the phase II PHAROS study of encorafenib plus binimetinib in patients with BRAF V600E-mutant metastatic NSCLC (mNSCLC)ANNALS OF ONCOLOGY, 2024, 35 : 1246 - 1247Riely, G. J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAAhn, M-J.论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Hematol Oncol Dept, Seoul, South Korea Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAClarke, J.论文数: 0 引用数: 0 h-index: 0机构: Duke Canc Inst, Dept Med, Durham, NC USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USADagogo-Jack, I.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAFelip, E.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Oncol Dept, Barcelona, Spain Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAGelsomino, F.论文数: 0 引用数: 0 h-index: 0机构: IRCCS Azienda Osped Univ Bologna, Dept Oncol & Hematol, Bologna, Italy Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAGoldman, J. W.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAHussein, M.论文数: 0 引用数: 0 h-index: 0机构: Florida Canc Specialists, Sarah Cannon Res Inst, Leesburg, FL USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAJohnson, M. L.论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAMorgensztern, D.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USANadal, E.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol, Med Oncol, Barcelona, Spain Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAOffin, M. D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAProvencio Pulla, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Puerta de Hierro Majadahonda, Med Oncol Dept, Madrid, Spain Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USARamalingam, S. S.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USASmit, E. F.论文数: 0 引用数: 0 h-index: 0机构: Leiden Univ, Med Ctr, Dept Pulm Dis, Leiden, Netherlands Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USATsao, A. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAAlcasid, A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Pfizer Oncol Div, Collegeville, PA USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAUsari, T.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Pfizer Oncol Div, Milan, Italy Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAWilner, K.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Pfizer Oncol Div, La Jolla, CA USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USAJohnson, B.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol Emeritus, Boston, MA 02115 USA Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
- [44] Quality-of-Life (QoL) in COLUMBUS Part 1: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus Vemurafenib (VEM) or ENCO in BRAF-Mutant MelanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 45 - 45Berking, Carola论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Munich, Dept Dermatol, Munich, Germany Univ Hosp Munich, Dept Dermatol, Munich, GermanyAscierto, Paolo A.论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori Fdn Pascale, Naples, Italy Univ Hosp Munich, Dept Dermatol, Munich, GermanyGogas, Helen J.论文数: 0 引用数: 0 h-index: 0机构: Univ Athens, Laikon Hosp, Athens, Greece Univ Hosp Munich, Dept Dermatol, Munich, GermanyArance, Ana论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Barcelona, Spain Univ Hosp Munich, Dept Dermatol, Munich, GermanyMandala, Mario论文数: 0 引用数: 0 h-index: 0机构: Papa Giovanni XXIII Canc Ctr Hosp, Bergamo, Italy Univ Hosp Munich, Dept Dermatol, Munich, GermanyLiszkay, Gabriella论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Oncol, Budapest, Hungary Univ Hosp Munich, Dept Dermatol, Munich, GermanyGarbe, Claus论文数: 0 引用数: 0 h-index: 0机构: Eberhard Karls Univ Tubingen, Tubingen, Germany Univ Hosp Munich, Dept Dermatol, Munich, GermanySchadendorf, Dirk论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Essen, Essen, Germany German Canc Consortium, Heidelberg, Germany Univ Hosp Munich, Dept Dermatol, Munich, GermanyKrajsova, Ivana论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Prague, Prague, Czech Republic Charles Univ Prague, Fac Med 1, Prague, Czech Republic Univ Hosp Munich, Dept Dermatol, Munich, GermanyGutzmer, Ralf论文数: 0 引用数: 0 h-index: 0机构: Hannover Med Sch, Hannover, Germany Univ Hosp Munich, Dept Dermatol, Munich, GermanySileni, Vanna Chiarion论文数: 0 引用数: 0 h-index: 0机构: Veneto IRCCS, Inst Oncol, Padua, Italy Univ Hosp Munich, Dept Dermatol, Munich, GermanyDutriaux, Caroline论文数: 0 引用数: 0 h-index: 0机构: Hop St Andre, Ctr Hosp Univ Bordeaux, Bordeaux, France Univ Hosp Munich, Dept Dermatol, Munich, Germanyde Groot, Jan Willem B.论文数: 0 引用数: 0 h-index: 0机构: Isala, Zwolle, Netherlands Univ Hosp Munich, Dept Dermatol, Munich, GermanyYamazaki, Naoya论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Tokyo, Japan Univ Hosp Munich, Dept Dermatol, Munich, GermanyLoquai, Carmen论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Mainz, Germany Univ Hosp Munich, Dept Dermatol, Munich, Germanyde Parseval, Laure A.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Basel, Switzerland Univ Hosp Munich, Dept Dermatol, Munich, GermanyPickard, Michael论文数: 0 引用数: 0 h-index: 0机构: Array BioPharma Inc, Boulder, CO USA Univ Hosp Munich, Dept Dermatol, Munich, GermanySandor, Victor论文数: 0 引用数: 0 h-index: 0机构: Array BioPharma Inc, Boulder, CO USA Univ Hosp Munich, Dept Dermatol, Munich, GermanyRobert, Caroline论文数: 0 引用数: 0 h-index: 0机构: Inst Gustave Roussy, Villejuif, France Univ Hosp Munich, Dept Dermatol, Munich, GermanyFlaherty, Keith T.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA Univ Hosp Munich, Dept Dermatol, Munich, GermanyDummer, Reinhard论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Zurich, Skin Canc Ctr, Zurich, Switzerland Univ Hosp Munich, Dept Dermatol, Munich, Germany
- [45] Matching-adjusted indirect comparison of nivolumab plus ipilimumab and BRAF plus MEK inhibitors for the treatment of BRAF-mutant treatment-naive advanced melanomaCANCER RESEARCH, 2018, 78 (13)Atkins, Michael B.论文数: 0 引用数: 0 h-index: 0机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USAMcDermott, David论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USATarhini, Ahmad论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Ctr Immunooncol Res, Cleveland, OH 44106 USA Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USARael, Michael论文数: 0 引用数: 0 h-index: 0机构: Evidera Inc, San Francisco, CA USA Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USAGupte-Singh, Komal论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USAO'Brien, Elliot论文数: 0 引用数: 0 h-index: 0机构: Evidera Inc, San Francisco, CA USA Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USARitchings, Corey论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USARao, Sumati论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
- [46] Retrospective individual case reports on the treatment of patients with advanced BRAFV600-mutant malignant melanoma with encorafenib plus binimetinib (REMINISCENCE): focus on patients with brain metastasesJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 79 - 80Debus, D.论文数: 0 引用数: 0 h-index: 0机构: Klinikum Nurnberg Nord, Klin Dermatol, Hauttumor Zentrum, Nurnberg, Germany Klinikum Nurnberg Nord, Klin Dermatol, Hauttumor Zentrum, Nurnberg, GermanyRohrer, P.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Graz, Univ Klin Dermatol & Venerol, Graz, Austria Klinikum Nurnberg Nord, Klin Dermatol, Hauttumor Zentrum, Nurnberg, GermanyGrote, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Schleswig Holstein, Klin Dermatol Venerol & Allergol, Campus Kiel, Kiel, Germany Klinikum Nurnberg Nord, Klin Dermatol, Hauttumor Zentrum, Nurnberg, GermanyKaehler, K. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Schleswig Holstein, Klin Dermatol Venerol & Allergol, Campus Kiel, Kiel, Germany Klinikum Nurnberg Nord, Klin Dermatol, Hauttumor Zentrum, Nurnberg, GermanyKoch, L.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Graz, Univ Klin Dermatol & Venerol, Graz, Austria Klinikum Nurnberg Nord, Klin Dermatol, Hauttumor Zentrum, Nurnberg, GermanyReichenbach, F.论文数: 0 引用数: 0 h-index: 0机构: Pierre Fabre Pharma GmbH, Oncol DACH, Freiburg, Germany Klinikum Nurnberg Nord, Klin Dermatol, Hauttumor Zentrum, Nurnberg, GermanyTerheyden, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Schleswig Holstein, Klin Dermatol Allergol & Venerol, Camp Lubeck, Lubeck, Germany Klinikum Nurnberg Nord, Klin Dermatol, Hauttumor Zentrum, Nurnberg, GermanyNguyen, V. A.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Innsbruck, Univ Klin Dermatol Venerol & Allergol, Innsbruck, Austria Klinikum Nurnberg Nord, Klin Dermatol, Hauttumor Zentrum, Nurnberg, Germany
- [47] Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of CareBioDrugs, 2017, 31 : 51 - 61Ester Simeone论文数: 0 引用数: 0 h-index: 0机构: Istituto Nazionale Tumori di Napoli Fondazione “G. Pascale”,Melanoma, Cancer Immunotherapy and Innovative Therapies UnitAntonio M. Grimaldi论文数: 0 引用数: 0 h-index: 0机构: Istituto Nazionale Tumori di Napoli Fondazione “G. Pascale”,Melanoma, Cancer Immunotherapy and Innovative Therapies UnitLucia Festino论文数: 0 引用数: 0 h-index: 0机构: Istituto Nazionale Tumori di Napoli Fondazione “G. Pascale”,Melanoma, Cancer Immunotherapy and Innovative Therapies UnitVito Vanella论文数: 0 引用数: 0 h-index: 0机构: Istituto Nazionale Tumori di Napoli Fondazione “G. Pascale”,Melanoma, Cancer Immunotherapy and Innovative Therapies UnitMarco Palla论文数: 0 引用数: 0 h-index: 0机构: Istituto Nazionale Tumori di Napoli Fondazione “G. Pascale”,Melanoma, Cancer Immunotherapy and Innovative Therapies UnitPaolo A. Ascierto论文数: 0 引用数: 0 h-index: 0机构: Istituto Nazionale Tumori di Napoli Fondazione “G. Pascale”,Melanoma, Cancer Immunotherapy and Innovative Therapies Unit
- [48] Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of CareBIODRUGS, 2017, 31 (01) : 51 - 61Simeone, Ester论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, Italy Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, ItalyGrimaldi, Antonio M.论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, Italy Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, ItalyFestino, Lucia论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, Italy Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, ItalyVanella, Vito论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, Italy Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, ItalyPalla, Marco论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, Italy Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, ItalyAscierto, Paolo A.论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, Italy Ist Nazl Tumori Napoli Fdn G Pascale, Melanoma Canc Immunotherapy & Innovat Therapies U, Via Mariano Semmola, I-80131 Naples, Italy
- [49] Updated Safety Analysis of Encorafenib Plus Binimetinib in Patients with BRAF V600e-Mutant Metastatic NSCLC from PHAROS StudyJOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S77 - S78Smit, E.论文数: 0 引用数: 0 h-index: 0机构: Leiden Univ, Med Ctr, Leiden, Netherlands Leiden Univ, Med Ctr, Leiden, NetherlandsAhn, M-J论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea Leiden Univ, Med Ctr, Leiden, NetherlandsDagogo-Jack, I.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA USA Leiden Univ, Med Ctr, Leiden, NetherlandsFelip, E.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain Leiden Univ, Med Ctr, Leiden, NetherlandsGelsomino, F.论文数: 0 引用数: 0 h-index: 0机构: IRCCS Azienda Osped Univ Bologna, Bologna, Italy Leiden Univ, Med Ctr, Leiden, NetherlandsJohnson, B.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Leiden Univ, Med Ctr, Leiden, NetherlandsJohnson, M.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Tennessee Oncol, Nashville, TN USA Leiden Univ, Med Ctr, Leiden, NetherlandsNegrao, M. V.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Leiden Univ, Med Ctr, Leiden, NetherlandsOffin, M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY USA Leiden Univ, Med Ctr, Leiden, Netherlands论文数: 引用数: h-index:机构:Sanborn, R.论文数: 0 引用数: 0 h-index: 0机构: Providence Canc Inst, Earle A Chiles Res Inst, Providence, RI USA Leiden Univ, Med Ctr, Leiden, NetherlandsTsao, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA Leiden Univ, Med Ctr, Leiden, NetherlandsWilner, K.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, La Jolla, CA USA Leiden Univ, Med Ctr, Leiden, NetherlandsAlcasid, A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Collegeville, PA USA Leiden Univ, Med Ctr, Leiden, NetherlandsUsari, T.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Milan, Italy Leiden Univ, Med Ctr, Leiden, NetherlandsZhang, X.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Francisco, CA USA Leiden Univ, Med Ctr, Leiden, NetherlandsRiely, G.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY USA Leiden Univ, Med Ctr, Leiden, Netherlands
- [50] Multicenter phase I/II trial of encorafenib with and without binimetinib in combination with nivolumab and low-dose ipilimumab in metastatic BRAF-mutant melanoma.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Jameson-Lee, Max论文数: 0 引用数: 0 h-index: 0机构: UPMC Hillman Canc Ctr, Pittsburgh, PA USAOtt, Patrick Alexander论文数: 0 引用数: 0 h-index: 0机构: UPMC Hillman Canc Ctr, Pittsburgh, PA USALuke, Jason J.论文数: 0 引用数: 0 h-index: 0机构: UPMC Hillman Canc Ctr, Pittsburgh, PA USAPostow, Michael A.论文数: 0 引用数: 0 h-index: 0机构: UPMC Hillman Canc Ctr, Pittsburgh, PA USAPoklepovic, Andrew Stewart论文数: 0 引用数: 0 h-index: 0机构: UPMC Hillman Canc Ctr, Pittsburgh, PA USA